IE37189B1 - Pyrazolo (1,5a) pyrimidines - Google Patents
Pyrazolo (1,5a) pyrimidinesInfo
- Publication number
- IE37189B1 IE37189B1 IE1612/72A IE161272A IE37189B1 IE 37189 B1 IE37189 B1 IE 37189B1 IE 1612/72 A IE1612/72 A IE 1612/72A IE 161272 A IE161272 A IE 161272A IE 37189 B1 IE37189 B1 IE 37189B1
- Authority
- IE
- Ireland
- Prior art keywords
- alkyl
- effect
- pyrazolo
- compounds
- dec
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 206010021118 Hypotonia Diseases 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000003501 anti-edematous effect Effects 0.000 abstract 1
- 239000002579 antinauseant Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 230000005792 cardiovascular activity Effects 0.000 abstract 1
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical compound C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 abstract 1
- -1 dicarbonyl compound Chemical class 0.000 abstract 1
- 230000010339 dilation Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000036640 muscle relaxation Effects 0.000 abstract 1
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20653871A | 1971-12-09 | 1971-12-09 | |
| US245870A US3925385A (en) | 1972-04-20 | 1972-04-20 | 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines |
| US27346572A | 1972-07-20 | 1972-07-20 | |
| US29984072A | 1972-10-24 | 1972-10-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE37189L IE37189L (en) | 1973-06-09 |
| IE37189B1 true IE37189B1 (en) | 1977-05-25 |
Family
ID=27498614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1612/72A IE37189B1 (en) | 1971-12-09 | 1972-11-21 | Pyrazolo (1,5a) pyrimidines |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS4864097A (en:Method) |
| BE (1) | BE792533A (en:Method) |
| BG (1) | BG22401A3 (en:Method) |
| CH (1) | CH603652A5 (en:Method) |
| DD (1) | DD104530A5 (en:Method) |
| DE (1) | DE2257547A1 (en:Method) |
| GB (1) | GB1412017A (en:Method) |
| HU (1) | HU168530B (en:Method) |
| IE (1) | IE37189B1 (en:Method) |
| IL (1) | IL40895A (en:Method) |
| LU (1) | LU66597A1 (en:Method) |
| NL (1) | NL7216539A (en:Method) |
| NO (1) | NO137012C (en:Method) |
| RO (1) | RO62762A (en:Method) |
| SE (1) | SE398751B (en:Method) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
| AU557300B2 (en) * | 1982-03-16 | 1986-12-18 | Farmitalia Carlo Erba S.P.A. | Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation |
| ZA831407B (en) * | 1982-03-25 | 1983-11-30 | Erba Farmitalia | Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation |
| NZ208554A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions |
| DE3533050A1 (de) * | 1985-09-17 | 1987-03-26 | Basf Ag | 7-amino-azolo(1,5-a)pyrimidine, verfahren zu ihrer herstellung und diese enthaltende fungizide, bzw. deren verwendung als fungizide |
| CA1330079C (en) * | 1988-10-13 | 1994-06-07 | Michihiko Tsujitani | Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same |
| ES2126573T3 (es) * | 1991-04-22 | 1999-04-01 | Otsuka Pharma Co Ltd | Derivado de pirazol (1,5-a)pirimidina y agente antiinflamatorio que contiene este derivado. |
| DE4333705C2 (de) * | 1993-10-02 | 2003-10-30 | Guenter Ege | Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen |
| EP0714898B1 (en) * | 1994-06-21 | 2001-11-14 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE |
| CN1169149A (zh) * | 1995-09-28 | 1997-12-31 | 株式会社大制药工场 | 止痛组合物 |
| FR2771631B1 (fr) | 1997-12-03 | 2001-02-02 | Oreal | Compositions de teinture des fibres keratiniques contenant des 3-amino pyrazolo-[1,5-a]-pyrimidines, procede de teinture, nouvelles 3-amino pyrazolo- [1,5-a]-pyrimidines et leur procede de preparation |
| US7161003B1 (en) | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| AU2003263071B2 (en) * | 2002-09-04 | 2007-03-15 | Merck Sharp & Dohme Llc | Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| US7119200B2 (en) * | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| TWI252851B (en) * | 2003-07-24 | 2006-04-11 | Ferrer Int | 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto |
| ES2222813B1 (es) * | 2003-07-24 | 2005-12-16 | Ferrer Internacional, S.A. | N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados. |
| EP2989106B1 (en) | 2013-04-25 | 2016-12-14 | Beigene, Ltd. | Fused heterocyclic compounds as protein kinase inhibitors |
| AU2013400609B9 (en) | 2013-09-13 | 2020-03-05 | Beigene Switzerland Gmbh | Anti-PD1 antibodies and their use as therapeutics and diagnostics |
| TWI726608B (zh) | 2014-07-03 | 2021-05-01 | 英屬開曼群島商百濟神州有限公司 | 抗pd-l1抗體及其作為治療及診斷之用途 |
| CN109475536B (zh) | 2016-07-05 | 2022-05-27 | 百济神州有限公司 | 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合 |
| EA201990519A1 (ru) | 2016-08-16 | 2019-08-30 | Бейджин, Лтд. | КРИСТАЛЛИЧЕСКАЯ ФОРМА (S)-7-(1-АКРИЛОИЛПИПЕРИДИН-4-ИЛ)-2-(4-ФЕНОКСИФЕНИЛ)-4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРИМИДИН-3-КАРБОКСАМИДА, ЕЕ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЯ |
| EP3500299B1 (en) | 2016-08-19 | 2023-12-13 | BeiGene Switzerland GmbH | Combination of zanubrutinib with an anti-cd20 or an anti-pd-1 antibody for use in treating cancer |
| CN110461847B (zh) | 2017-01-25 | 2022-06-07 | 百济神州有限公司 | (S)-7-(1-(丁-2-炔酰基)哌啶-4-基)-2-(4-苯氧基苯基)-4,5,6,7-四氢吡唑并[1,5-a]嘧啶-3-甲酰胺的结晶形式、其制备及用途 |
| EP3645569A4 (en) | 2017-06-26 | 2021-03-24 | BeiGene, Ltd. | IMMUNOTHERAPY FOR LIVER CELL CARCINOMA |
| WO2019034009A1 (en) | 2017-08-12 | 2019-02-21 | Beigene, Ltd. | BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY |
| CN111801334B (zh) | 2017-11-29 | 2023-06-09 | 百济神州瑞士有限责任公司 | 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤 |
| JP2022538214A (ja) | 2019-06-10 | 2022-09-01 | ベイジーン スウィッツァーランド ゲーエムベーハー | ブルトン型チロシンキナーゼ阻害剤を含む経口固体錠剤及びその調製方法 |
| US11786531B1 (en) | 2022-06-08 | 2023-10-17 | Beigene Switzerland Gmbh | Methods of treating B-cell proliferative disorder |
-
0
- BE BE792533D patent/BE792533A/xx unknown
-
1972
- 1972-11-21 IE IE1612/72A patent/IE37189B1/xx unknown
- 1972-11-22 IL IL40895A patent/IL40895A/en unknown
- 1972-11-23 DE DE2257547A patent/DE2257547A1/de active Pending
- 1972-12-01 GB GB5558772A patent/GB1412017A/en not_active Expired
- 1972-12-05 SE SE7215829A patent/SE398751B/xx unknown
- 1972-12-05 LU LU66597A patent/LU66597A1/xx unknown
- 1972-12-06 NL NL7216539A patent/NL7216539A/xx not_active Application Discontinuation
- 1972-12-06 CH CH1775172A patent/CH603652A5/xx not_active IP Right Cessation
- 1972-12-06 NO NO4476/72A patent/NO137012C/no unknown
- 1972-12-07 DD DD167370A patent/DD104530A5/xx unknown
- 1972-12-08 HU HUIE548A patent/HU168530B/hu unknown
- 1972-12-09 BG BG022071A patent/BG22401A3/xx unknown
- 1972-12-09 JP JP47123877A patent/JPS4864097A/ja active Pending
- 1972-12-09 RO RO7200073093A patent/RO62762A/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DD104530A5 (en:Method) | 1974-03-12 |
| HU168530B (en:Method) | 1976-05-28 |
| JPS4864097A (en:Method) | 1973-09-05 |
| IE37189L (en) | 1973-06-09 |
| SE398751B (sv) | 1978-01-16 |
| IL40895A0 (en) | 1973-01-30 |
| DE2257547A1 (de) | 1973-06-14 |
| CH603652A5 (en:Method) | 1978-08-31 |
| NL7216539A (en:Method) | 1973-06-13 |
| IL40895A (en) | 1976-12-31 |
| RO62762A (fr) | 1978-05-15 |
| LU66597A1 (en:Method) | 1973-03-15 |
| BG22401A3 (bg) | 1977-02-20 |
| GB1412017A (en) | 1975-10-29 |
| BE792533A (fr) | 1973-06-08 |
| NO137012C (no) | 1977-12-14 |
| NO137012B (no) | 1977-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE37189B1 (en) | Pyrazolo (1,5a) pyrimidines | |
| IE36947B1 (en) | New esters their production and their medicinal use | |
| GB1528807A (en) | Pyrazolo(1,5-a)pyridines | |
| IE36383L (en) | Aryl guanidines | |
| GB1181146A (en) | Bis-Thiosemicarbazones and a process for their manufacture | |
| GB1276968A (en) | Improvements in or relating to phenylacetamides and the preparation thereof | |
| GB1417104A (en) | Imidazo 1,2-a- azacycloalkanes | |
| IE36623B1 (en) | Benzodiazepine dervatives | |
| GB1354431A (en) | Thiophene and furan derivatives | |
| GB1361863A (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
| GB1394791A (en) | Diphenylalkyllactamimide derivatives | |
| GB1373333A (en) | Pyrazole derivatives | |
| GB1384523A (en) | Oxime derivatives and their preparation | |
| GB1394184A (en) | 4,5-dihydropyridazine-3 2h- ones | |
| GB1184826A (en) | Substituted Aryloxy Hydroxy Amines | |
| GB1332766A (en) | Triazolo-benzodiazepines | |
| IE39926B1 (en) | Compositions containing indanyloxyalkanoic acid compounds | |
| GB1362144A (en) | Thiophene flavouring agents | |
| GB1444558A (en) | Pyridylthioureas | |
| GB1325280A (en) | 3-substituted-as-triazino-5,6-c-quinolines | |
| GB1437149A (en) | Spiro-compounds and a process for their preparation | |
| IE33446B1 (en) | New isothiocyano-diphenylamines their production and compositions containing same | |
| GB1315287A (en) | Thieno-2,3-e 1,4 diazepine compounds methods for their production and pharmaceutical compositions containing them | |
| GB1329493A (en) | N-alkyl-pyridyl-furamides | |
| GB1395929A (en) | Thioureas |